Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The admissions cycle for entry in October 2024 is now open. Please continue to check this webpage for new opportunities as they are added. Please contact the supervisor to check that the research opportunity is still available.

Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL) Monique Andersson
Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases Alison Simmons
Antanaviciute Group - Characterising spatial tissue niches in human immune system development and disease using computational biology, machine learning and multi-omics approaches Agne Antanaviciute
Koohy Group - Applications of multi-omics and AI to decode T cell recognition code in time and space Hashem Koohy
Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway Usha Kini
Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart Damian Tyler
Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies Ronjon Chakraverty
Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets Charalambos Antoniades
Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes Gillian Douglas
Karpe Group - Human fat distribution and metabolic disease Fredrik Karpe
Cai Group - Inflammatory infiltration induces cancer-associated fibroblast differentiation Shijie Cai
Leeson Group - Imaging in Preventive Cardiology Research Paul Leeson
Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Svetlana Reilly
Tzima Group - Why does turbulent blood flow cause cardiovascular disease? Ellie Tzima
Watkins Group – Various projects relating to inherited heart muscle disease Hugh Watkins
Drakesmith Group - Iron Biology Hal Drakesmith
Goriely Group - De Novo Mutations and Human Disease Anne Goriely
Higgs Group - Understanding the principles of gene expression in health and disease. Douglas Higgs
Mead Group - Inflammation in p53 mutant myeloproliferative neoplasms Adam Mead
Psaila Group - Developing improved models of normal and malignant blood cell development Bethan Psaila
Vyas Group - New Immune Therapies For Acute Myeloid Leukaemia (AML) And Myeloid Blood Cancers. Paresh Vyas
Twigg Group - Building the skull – normal and abnormal development Stephen Twigg
Nerlov Group - Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing Claus Nerlov
Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 Christopher Toepfer
Hyde Group - Airway Gene Therapy - Engineering Lentiviral Vectors for Lung Cell-Specific Targeting Stephen Hyde
Chapman Group - Homologous recombination in genome maintenance and cancer prevention Ross Chapman
Zhang Group - AI deep generative models for contrast enhancement of MRI: Towards needle-free and more informative MRI examination of the heart Qiang Zhang
Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease Michael Pavlides
Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis James Grist
Davies Group – Genomics and Genome Editing James Davies
Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Simon Davis
Vyas Group - Single Cell Biology, Molecular Mechanisms And Genetics of Transformation of Clonal Haemopoiesis to Myeloid Blood Cancer (MDS and AML) Paresh Vyas
David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson
Reader Group - How do protein making factories prevent cardiovascular disease? John Reader
Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation. Elizabeth Ormondroyd
Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging
Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis KJ Patel
Leeson Group - Developing new echocardiography diagnostics with AI Paul Leeson
Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Ladislav Valkovic
Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Naveed Akbar